1. Search Result

Search Result

Targets Recommended: NEDD8-activating Enzyme

Results for "2170729-29-8" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-129586
    AT-007

    Aldose Reductase Metabolic Disease
    AT-007 is an orally active central nervous system (CNS) penetrant Aldose Reductase inhibitor for treatment of Galactosemia with an IC50 value of 100 pM. AT-007 reduces toxic galactitol levels and prevents disease complications in GALT deficiency rats.